Cardiac Troponin Global Market Report 2025

Description

Cardiac troponin refers to a set of proteins located in the heart muscle (myocardium) that play a crucial role in regulating heart contractions. These troponins are components of the muscle fiber proteins that manage the interaction between actin and myosin, which are vital for muscle contraction. They serve as biomarkers used for diagnosing heart injuries, particularly in the case of heart attacks.

The primary types of cardiac troponin are troponin I and troponin T. Troponin I is a protein present in heart muscle cells that aids in the regulation of muscle contractions, and increased levels of Troponin I in the bloodstream may indicate heart injury or stress, making it critical for precise cardiac diagnostics. Testing can be conducted in laboratory environments as well as through point-of-care (PoC) testing, applicable in scenarios such as acute coronary syndrome, myocardial infarction, and congestive heart failure, among others. The end users of this testing include hospitals, diagnostic centers, home care settings, and more.

The cardiac troponin market research report is one of a series of new reports from the business research company that provides cardiac troponin market statistics, including cardiac troponin industry global market size, regional shares, competitors with an cardiac troponin market share, detailed cardiac troponin market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac troponin industry. This cardiac troponin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac troponin market size has grown rapidly in recent years. It will grow from $3.85 billion in 2024 to $4.25 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, increasing awareness and early diagnosis of heart conditions, expanding healthcare infrastructure in emerging markets, growth in the elderly population, introduction of high-sensitivity cardiac troponin assays.

The cardiac troponin market size is expected to see rapid growth in the next few years. It will grow to $6.32 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to rising prevalence of lifestyle-related cardiovascular conditions, expansion of cardiac care units in hospitals, increasing adoption of home healthcare, growth in personalized medicine, and demand for more efficient and cost-effective diagnostic solutions. Major trends in the forecast period include adoption of machine learning algorithms for data interpretation in cardiac care, expanding applications of cardiac troponin beyond acute coronary syndrome, advancements in multiplex testing for simultaneous biomarker analysis, development of novel biomarkers alongside troponin, and personalized medicine.

The rising incidence of heart-related diseases is anticipated to drive the growth of the cardiac troponin market in the future. These diseases include various cardiovascular issues such as coronary artery disease, heart failure, arrhythmias, and congenital heart defects, all of which impact the heart's structure and functionality. Factors contributing to this increasing prevalence include aging populations, sedentary lifestyles, unhealthy dietary habits, and escalating rates of obesity and hypertension. Cardiac troponin plays a vital role in diagnosing heart-related issues as it serves as a highly sensitive biomarker for identifying heart muscle damage, especially in the context of heart attacks and other cardiac events. For example, the Report on Registration of Births and Deaths 2023 from Singapore's Immigration and Checkpoints Authority and Ministry of Health indicated that deaths from ischemic heart diseases totaled 5,302, marking a slight rise from 5,290 in 2022. Thus, the growing prevalence of heart conditions is expected to boost the cardiac troponin market.

Key players in the cardiac troponin market are concentrating on developing new technologies, such as human serum-based quality control, to enhance the accuracy and reliability of high-sensitivity troponin testing through multi-analyte controls. This quality control approach utilizes human serum with known troponin levels to validate assay performance. For instance, in May 2023, Bio-Rad Laboratories, Inc., a biotechnology research firm based in the U.S., launched Cardiac Advance, a multi-analyte quality control system specifically tailored for high-sensitivity troponin testing. These liquid, human-serum-based controls are provided in InteliQ 3-mL tubes, Liquichek 3-mL standards, and 2.5-mL compact vials. They include 10 cardiac analytes, such as troponin, CK-MB, BNP/proBNP, and myoglobin, and are compatible with testing platforms from Siemens and Roche. These products are available in the U.S., Europe, and select Asian markets.

In February 2022, Prolight Diagnostics AB, a Swedish medical equipment manufacturer, acquired Psyros Diagnostics Ltd. for $5.78 million. This acquisition aims to integrate Psyros Diagnostics' advanced single-molecule counting technology into Prolight Diagnostics' offerings, resulting in the development of highly sensitive, rapid, and cost-effective point-of-care (POC) testing solutions. This move enhances their capabilities across various clinical areas and solidifies their presence in the POC market. Psyros Diagnostics Ltd., a UK-based company, has created the Psyros POC system, a device designed to measure the cardiac troponin biomarker.

Major companies operating in the cardiac troponin market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, Laboratory Corporation of America Holdings (Labcorp), Zoetis Inc., bioMerieux SA, Beckman Coulter Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Radiometer Medical ApS, Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Meso Scale Diagnostics LLC., Singulex Inc., Diazyme Laboratories Inc., Response Biomedical Corporation, Eurolyser Diagnostica GmbH, LifeSign LLC

North America was the largest region in the cardiac troponin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac troponin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiac troponin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiac troponin market consists of sales of diagnostic assays, test kits, point-of-care testing devices, and high-sensitivity troponin tests. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac Troponin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac troponin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac troponin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiac troponin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Troponin I; Troponin T
2) By Location Of Testing: Laboratory Setting; Point Of Care (Poc) Testing
3) By Application: Acute Coronary Syndrome; Myocardial Infraction; Congestive Heart Failure; Other Applications
4) By End User: Hospitals; Diagnostic Centers; Homecare Setting; Other End Users
Subsegments:
1) By Troponin I: Cardiac Troponin I (cTnI); Muscle Troponin I
2) By Troponin T: Cardiac Troponin T (cTnT); Skeletal Troponin T
Companies Mentioned: F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Abbott Laboratories; Merck KGaA; Siemens Healthineers AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r31700

1. Executive Summary

2. Cardiac Troponin Market Characteristics

3. Cardiac Troponin Market Trends And Strategies

4. Cardiac Troponin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cardiac Troponin Growth Analysis And Strategic Analysis Framework

5.1. Global Cardiac Troponin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Cardiac Troponin Market Growth Rate Analysis
5.4. Global Cardiac Troponin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Cardiac Troponin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Cardiac Troponin Total Addressable Market (TAM)

6. Cardiac Troponin Market Segmentation

6.1. Global Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Troponin I
Troponin T
6.2. Global Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Laboratory Setting
Point Of Care (Poc) Testing
6.3. Global Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acute Coronary Syndrome
Myocardial Infraction
Congestive Heart Failure
Other Applications
6.4. Global Cardiac Troponin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Diagnostic Centres
Homecare Setting
Other End Users
6.5. Global Cardiac Troponin Market, Sub-Segmentation Of Troponin I, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cardiac Troponin I (cTnI)
Muscle Troponin I
6.6. Global Cardiac Troponin Market, Sub-Segmentation Of Troponin T, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cardiac Troponin T (cTnT)
Skeletal Troponin T

7. Cardiac Troponin Market Regional And Country Analysis

7.1. Global Cardiac Troponin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Cardiac Troponin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiac Troponin Market

8.1. Asia-Pacific Cardiac Troponin Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiac Troponin Market

9.1. China Cardiac Troponin Market Overview
9.2. China Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiac Troponin Market

10.1. India Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiac Troponin Market

11.1. Japan Cardiac Troponin Market Overview
11.2. Japan Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiac Troponin Market

12.1. Australia Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiac Troponin Market

13.1. Indonesia Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiac Troponin Market

14.1. South Korea Cardiac Troponin Market Overview
14.2. South Korea Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiac Troponin Market

15.1. Western Europe Cardiac Troponin Market Overview
15.2. Western Europe Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiac Troponin Market

16.1. UK Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiac Troponin Market

17.1. Germany Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiac Troponin Market

18.1. France Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiac Troponin Market

19.1. Italy Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiac Troponin Market

20.1. Spain Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiac Troponin Market

21.1. Eastern Europe Cardiac Troponin Market Overview
21.2. Eastern Europe Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiac Troponin Market

22.1. Russia Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiac Troponin Market

23.1. North America Cardiac Troponin Market Overview
23.2. North America Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiac Troponin Market

24.1. USA Cardiac Troponin Market Overview
24.2. USA Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiac Troponin Market

25.1. Canada Cardiac Troponin Market Overview
25.2. Canada Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiac Troponin Market

26.1. South America Cardiac Troponin Market Overview
26.2. South America Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiac Troponin Market

27.1. Brazil Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiac Troponin Market

28.1. Middle East Cardiac Troponin Market Overview
28.2. Middle East Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiac Troponin Market

29.1. Africa Cardiac Troponin Market Overview
29.2. Africa Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiac Troponin Market Competitive Landscape And Company Profiles

30.1. Cardiac Troponin Market Competitive Landscape
30.2. Cardiac Troponin Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Cardiac Troponin Market Other Major And Innovative Companies

31.1. Becton Dickinson and Company
31.2. Laboratory Corporation of America Holdings (Labcorp)
31.3. Zoetis Inc.
31.4. bioMerieux SA
31.5. Beckman Coulter Inc.
31.6. QuidelOrtho Corporation
31.7. Sysmex Corporation
31.8. Bio-Rad Laboratories Inc.
31.9. Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
31.10. Radiometer Medical ApS
31.11. Randox Laboratories Ltd.
31.12. Fujirebio Diagnostics Inc.
31.13. Meso Scale Diagnostics LLC.
31.14. Singulex Inc.
31.15. Diazyme Laboratories Inc.

32. Global Cardiac Troponin Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiac Troponin Market

34. Recent Developments In The Cardiac Troponin Market

35. Cardiac Troponin Market High Potential Countries, Segments and Strategies

35.1 Cardiac Troponin Market In 2029 - Countries Offering Most New Opportunities
35.2 Cardiac Troponin Market In 2029 - Segments Offering Most New Opportunities
35.3 Cardiac Troponin Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer